Family · Pharmaceutical analytical standards
Framycetin
An aminoglycoside antibiotic identical to neomycin B, the most active component of neomycin, discovered in 1949 by Selman Waksman and Hubert Lechevalier; it is used mainly in topical preparations such as creams, ointments and eye drops. This family brings together the active ingredient and other impurities.
Did you know?It had been described as a separate antibiotic, with the code EF 185: only later was it shown to be the same molecule as neomycin B.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
